Establishing First Trimester Markers for the Identification of High Risk Twin
NCT02031393 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2014-01-31
Summary
The purpose of this study is to determine whether we can establish different markers suc as mean arterial pressure , flow in the uterine arteries, biochemical markers in maternal blood and more un the first trimester, in order to screen for twin pregnancies that are more likely to develop adverse pregnancy outcome: early delivery, pre eclampsia or small fetuses.
Conditions
- Small for Gestational Age (Disorder)
- Pre-Eclampsia
Sponsors & Collaborators
-
Assaf-Harofeh Medical Center
lead OTHER_GOV
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-09-30
- Primary Completion
- 2014-01-31
- Completion
- 2014-07-31
Countries
- Israel
Study Locations
More Related Trials
-
Clinical Utility of the Addition of a SNP-based NIPT Zygosity Determination in Twin Pregnancy Management.
NCT05312814 ·Status: COMPLETED
-
Non-invasive Chromosomal Examination of Trisomy Study
NCT01511458 ·Status: COMPLETED
-
Low-dose Aspirin for Prevention of Adverse Pregnancy Outcomes in Twin Pregnancies
NCT04051567 ·Status: UNKNOWN ·Phase: PHASE4
-
Early Ultrasound and Maternal Biochemical Markers to Evaluate the Risk of Down Syndrome During the First Trimester
NCT00287417 ·Status: COMPLETED
-
Preterm Delivery Risk Prediction by Measurement of Prenatal Serum Screening Markers
NCT01009723 ·Status: UNKNOWN
-
Prenatal Screening, Diagnosis and Intrauterine Intervention of Fetal Abnormal Chromosome and Structure in Twins Pregnancy
NCT02982356 ·Status: UNKNOWN ·Phase: NA
-
Comprehensive Assessment of Risks for Miscarriage.
NCT04456660 ·Status: RECRUITING
-
First-trimester Prediction of Preeclampsia
NCT02189148 ·Status: COMPLETED
-
Maternal Fetal Device Performance Twins
NCT06835647 ·Status: RECRUITING ·Phase: NA
-
Study of Coagulation Activation Markers and Pre Eclampsia
NCT01261351 ·Status: COMPLETED
-
The Efficacy of Aspirin Combined With Hydroxychloroquine Treatment in High Risk Pregnancies for Preeclampsia
NCT05287321 ·Status: RECRUITING ·Phase: PHASE3
-
First Trimester Prediction of Preeclampsia and Fetal Growth Restriction
NCT02379494 ·Status: COMPLETED
-
Cardiovascular an Echocardiographic Assessment in Hypertension During Pregnancy
NCT01068002 ·Status: COMPLETED
-
Left Ventricular and Endothelial Function in Preeclampsia
NCT00201500 ·Status: COMPLETED
-
Clinical Performance of NIPT in Multiple Gestation Pregnancies
NCT04488393 ·Status: COMPLETED
-
High Risk Multiple Gestation Study
NCT02278874 ·Status: COMPLETED
-
The NICHD Fetal Growth Study: Twin Gestations
NCT01369940 ·Status: COMPLETED
-
Non-Invasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
NCT00770458 ·Status: COMPLETED
-
Biological Changes Associated With High Risk of Preeclampsia in Nulliparous Women
NCT06200571 ·Status: ENROLLING_BY_INVITATION
-
Prevention of Pre-eclampsia and SGA by Low-Dose Aspirin in Nulliparous Women With Abnormal First-trimester Uterine Artery Dopplers
NCT01729468 ·Status: COMPLETED ·Phase: PHASE4
-
Risk Factors of Ectopic Pregnancy
NCT00194207 ·Status: COMPLETED
-
Serum Markers in Preeclamptic Women
NCT01361737 ·Status: COMPLETED
-
Association of Assisted Reproductive Technologies Parameters With the Perinatal Outcome
NCT06918236 ·Status: RECRUITING
-
Median Study for Biochemical Serum Markers in First Trimester of Pregnancy
NCT01891370 ·Status: COMPLETED
-
Detection and Identification of Preeclampsia Via Volatile Biomarkers
NCT01291342 ·Status: COMPLETED